K2M has obtained the US Food and Drug Administration's (FDA) 510(k) approval for its Santorini Corpectomy Cage Systems.

The Santorini cages which are manufactured from biocompatible PEEK polymer allow for an unobstructed view of the post-operative fusion.

The cages are available as Santorini Solid which helps in providing an enlarged graft space and Santorini Expandable allows for in-situ expansion with a locking clip to secure the desired height.

K2M president and CEO Eric Major said FDA clearance for SANTORINI is an important expansion of the company’s complex spine product offering, particularly in the areas of trauma and tumor spinal surgeries.

"As the first addition to K2M’s portfolio in 2012, we’re proud to offer surgeons and patients new products that continue to highlight our commitment to treating the full spectrum of spine pathologies," Major added.